{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:02:12Z","timestamp":1792674132469,"version":"4.5.0"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T00:00:00Z","timestamp":1549497600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"crossref","award":["MOP 125930"],"award-info":[{"award-number":["MOP 125930"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00401-019-01967-4","type":"journal-article","created":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T06:16:27Z","timestamp":1549520187000},"page":"801-823","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Beta-amyloid pathology in human brain microvessel extracts from the parietal cortex: relation with cerebral amyloid angiopathy and Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"137","author":[{"given":"Philippe","family":"Bourassa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyntia","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4203-0887","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Calon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,7]]},"reference":[{"key":"1967_CR1","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1136\/jnnp.2004.053561","volume":"76","author":"NT Aggarwal","year":"2005","unstructured":"Aggarwal NT, Wilson RS, Beck TL, Bienias JL, Bennett DA (2005) Mild cognitive impairment in different functional domains and incident Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 76:1479\u20131484","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1967_CR2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1021\/mp400421a","volume":"11","author":"W Alata","year":"2014","unstructured":"Alata W, Paris-Robidas S, Emond V, Bourasset F, Calon F (2014) Brain uptake of a fluorescent vector targeting the transferrin receptor: a novel application of in situ brain perfusion. Mol Pharm 11:243\u2013253","journal-title":"Mol Pharm"},{"key":"1967_CR3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/jcbfm.2014.172","volume":"35","author":"W Alata","year":"2015","unstructured":"Alata W, Ye Y, St-Amour I, Vandal M, Calon F (2015) Human apolipoprotein E varepsilon4 expression impairs cerebral vascularization and blood\u2013brain barrier function in mice. J Cereb Blood Flow Metab 35:86\u201394","journal-title":"J Cereb Blood Flow Metab"},{"key":"1967_CR4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/00005072-199804000-00008","volume":"57","author":"NC Alonzo","year":"1998","unstructured":"Alonzo NC, Hyman BT, Rebeck GW, Greenberg SM (1998) Progression of cerebral amyloid angiopathy: accumulation of amyloid-beta40 in affected vessels. J Neuropathol Exp Neurol 57:353\u2013359","journal-title":"J Neuropathol Exp Neurol"},{"key":"1967_CR5","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1212\/01.wnl.0000313813.48505.86","volume":"70","author":"Z Arvanitakis","year":"2008","unstructured":"Arvanitakis Z, Grodstein F, Bienias JL, Schneider JA, Wilson RS, Kelly JF et al (2008) Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology. Neurology 70:2219\u20132225","journal-title":"Neurology"},{"key":"1967_CR6","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1161\/STROKEAHA.110.595082","volume":"42","author":"Z Arvanitakis","year":"2011","unstructured":"Arvanitakis Z, Leurgans SE, Barnes LL, Bennett DA, Schneider JA (2011) Microinfarct pathology, dementia, and cognitive systems. Stroke 42:722\u2013727","journal-title":"Stroke"},{"key":"1967_CR7","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/ana.22112","volume":"69","author":"Z Arvanitakis","year":"2011","unstructured":"Arvanitakis Z, Leurgans SE, Wang Z, Wilson RS, Bennett DA, Schneider JA (2011) Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann Neurol 69:320\u2013327","journal-title":"Ann Neurol"},{"key":"1967_CR8","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1212\/01.wnl.0000288181.00826.63","volume":"70","author":"Z Arvanitakis","year":"2008","unstructured":"Arvanitakis Z, Schneider JA, Wilson RS, Bienias JL, Kelly JF, Evans DA et al (2008) Statins, incident Alzheimer disease, change in cognitive function, and neuropathology. Neurology 70:1795\u20131802","journal-title":"Neurology"},{"key":"1967_CR9","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00401-004-0822-6","volume":"107","author":"J Attems","year":"2004","unstructured":"Attems J, Lintner F, Jellinger KA (2004) Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology. Acta Neuropathol 107:283\u2013291","journal-title":"Acta Neuropathol"},{"key":"1967_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00401-009-0522-3","volume":"118","author":"RD Bell","year":"2009","unstructured":"Bell RD, Zlokovic BV (2009) Neurovascular mechanisms and blood\u2013brain barrier disorder in Alzheimer\u2019s disease. Acta Neuropathol 118:103\u2013113","journal-title":"Acta Neuropathol"},{"key":"1967_CR11","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1097\/00002093-200607001-00009","volume":"20","author":"DA Bennett","year":"2006","unstructured":"Bennett DA (2006) Postmortem indices linking risk factors to cognition: results from the religious order study and the memory and aging project. Alzheimer Dis Assoc Disord 20:S63\u2013S68","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1967_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1159\/000096129","volume":"27","author":"DA Bennett","year":"2006","unstructured":"Bennett DA, Schneider JA, Aggarwal NT, Arvanitakis Z, Shah RC, Kelly JF et al (2006) Decision rules guiding the clinical diagnosis of Alzheimer\u2019s disease in two community-based cohort studies compared to standard practice in a clinic-based cohort study. Neuroepidemiology 27:169\u2013176","journal-title":"Neuroepidemiology"},{"key":"1967_CR13","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1212\/01.wnl.0000219668.47116.e6","volume":"66","author":"DA Bennett","year":"2006","unstructured":"Bennett DA, Schneider JA, Arvanitakis Z, Kelly JF, Aggarwal NT, Shah RC et al (2006) Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 66:1837\u20131844","journal-title":"Neurology"},{"key":"1967_CR14","doi-asserted-by":"publisher","first-page":"628","DOI":"10.2174\/156720512801322573","volume":"9","author":"DA Bennett","year":"2012","unstructured":"Bennett DA, Schneider JA, Arvanitakis Z, Wilson RS (2012) Overview and findings from the religious orders study. Curr Alzheimer Res 9:628\u2013645","journal-title":"Curr Alzheimer Res"},{"key":"1967_CR15","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1212\/01.WNL.0000152982.47274.9E","volume":"64","author":"DA Bennett","year":"2005","unstructured":"Bennett DA, Schneider JA, Bienias JL, Evans DA, Wilson RS (2005) Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology 64:834\u2013841","journal-title":"Neurology"},{"key":"1967_CR16","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1212\/WNL.59.2.198","volume":"59","author":"DA Bennett","year":"2002","unstructured":"Bennett DA, Wilson RS, Schneider JA, Evans DA, Beckett LA, Aggarwal NT et al (2002) Natural history of mild cognitive impairment in older persons. Neurology 59:198\u2013205","journal-title":"Neurology"},{"key":"1967_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3988\/jcn.2011.7.1.1","volume":"7","author":"A Biffi","year":"2011","unstructured":"Biffi A, Greenberg SM (2011) Cerebral amyloid angiopathy: a systematic review. J Clin Neurol 7:1\u20139","journal-title":"J Clin Neurol"},{"key":"1967_CR18","doi-asserted-by":"crossref","unstructured":"Boulay AC, Saubamea B, Decleves X, Cohen-Salmon M (2015) Purification of Mouse Brain Vessels. J Vis Exp e53208","DOI":"10.3791\/53208"},{"key":"1967_CR19","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1212\/WNL.0000000000002175","volume":"85","author":"PA Boyle","year":"2015","unstructured":"Boyle PA, Yu L, Nag S, Leurgans S, Wilson RS, Bennett DA et al (2015) Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons. Neurology 85:1930\u20131936","journal-title":"Neurology"},{"key":"1967_CR20","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259","journal-title":"Acta Neuropathol"},{"key":"1967_CR21","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/BF00294173","volume":"87","author":"L Buee","year":"1994","unstructured":"Buee L, Hof PR, Bouras C, Delacourte A, Perl DP, Morrison JH et al (1994) Pathological alterations of the cerebral microvasculature in Alzheimer\u2019s disease and related dementing disorders. Acta Neuropathol 87:469\u2013480","journal-title":"Acta Neuropathol"},{"key":"1967_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1749-6632.1997.tb48457.x","volume":"826","author":"L Buee","year":"1997","unstructured":"Buee L, Hof PR, Delacourte A (1997) Brain microvascular changes in Alzheimer\u2019s disease and other dementias. Ann N Y Acad Sci 826:7\u201324","journal-title":"Ann N Y Acad Sci"},{"key":"1967_CR23","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1093\/jnen\/61.10.849","volume":"61","author":"M Carpentier","year":"2002","unstructured":"Carpentier M, Robitaille Y, DesGroseillers L, Boileau G, Marcinkiewicz M (2002) Declining expression of neprilysin in Alzheimer disease vasculature: possible involvement in cerebral amyloid angiopathy. J Neuropathol Exp Neurol 61:849\u2013856","journal-title":"J Neuropathol Exp Neurol"},{"key":"1967_CR24","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.neulet.2010.02.016","volume":"473","author":"RJ Caselli","year":"2010","unstructured":"Caselli RJ, Walker D, Sue L, Sabbagh M, Beach T (2010) Amyloid load in nondemented brains correlates with APOE e4. Neurosci Lett 473:168\u2013171","journal-title":"Neurosci Lett"},{"key":"1967_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.bbrc.2008.10.173","volume":"378","author":"KL Chen","year":"2009","unstructured":"Chen KL, Wang SS, Yang YY, Yuan RY, Chen RM, Hu CJ (2009) The epigenetic effects of amyloid-beta(1-40) on global DNA and neprilysin genes in murine cerebral endothelial cells. Biochem Biophys Res Commun 378:57\u201361","journal-title":"Biochem Biophys Res Commun"},{"key":"1967_CR26","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1172\/JCI25247","volume":"115","author":"JR Cirrito","year":"2005","unstructured":"Cirrito JR, Deane R, Fagan AM, Spinner ML, Parsadanian M, Finn MB et al (2005) P-glycoprotein deficiency at the blood\u2013brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. J Clin Invest 115:3285\u20133290","journal-title":"J Clin Invest"},{"key":"1967_CR27","doi-asserted-by":"publisher","first-page":"e0197379","DOI":"10.1371\/journal.pone.0197379","volume":"13","author":"M Dai","year":"2018","unstructured":"Dai M, Lin Y, El-Amouri SS, Kohls M, Pan D (2018) Comprehensive evaluation of blood\u2013brain barrier-forming micro-vasculatures: reference and marker genes with cellular composition. PLoS One 13:e0197379","journal-title":"PLoS One"},{"key":"1967_CR28","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1046\/j.1471-4159.1995.65020931.x","volume":"65","author":"J Davis-Salinas","year":"1995","unstructured":"Davis-Salinas J, Saporito-Irwin SM, Cotman CW, Van Nostrand WE (1995) Amyloid beta-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells. J Neurochem 65:931\u2013934","journal-title":"J Neurochem"},{"key":"1967_CR29","doi-asserted-by":"publisher","first-page":"4002","DOI":"10.1172\/JCI36663","volume":"118","author":"R Deane","year":"2008","unstructured":"Deane R, Sagare A, Hamm K, Parisi M, Lane S, Finn MB et al (2008) apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J Clin Invest 118:4002\u20134013","journal-title":"J Clin Invest"},{"key":"1967_CR30","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1177\/0271678X15606463","volume":"36","author":"K Devraj","year":"2016","unstructured":"Devraj K, Poznanovic S, Spahn C, Schwall G, Harter PN, Mittelbronn M et al (2016) BACE-1 is expressed in the blood\u2013brain barrier endothelium and is upregulated in a murine model of Alzheimer\u2019s disease. J Cereb Blood Flow Metab 36:1281\u20131294","journal-title":"J Cereb Blood Flow Metab"},{"key":"1967_CR31","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.neuropharm.2014.02.010","volume":"81","author":"TM Do","year":"2014","unstructured":"Do TM, Alata W, Dodacki A, Traversy MT, Chacun H, Pradier L et al (2014) Altered cerebral vascular volumes and solute transport at the blood\u2013brain barriers of two transgenic mouse models of Alzheimer\u2019s disease. Neuropharmacology 81:311\u2013317","journal-title":"Neuropharmacology"},{"key":"1967_CR32","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s00401-006-0115-3","volume":"112","author":"JE Donahue","year":"2006","unstructured":"Donahue JE, Flaherty SL, Johanson CE, Duncan JA 3rd, Silverberg GD, Miller MC et al (2006) RAGE, LRP-1, and amyloid-beta protein in Alzheimer\u2019s disease. Acta Neuropathol 112:405\u2013415","journal-title":"Acta Neuropathol"},{"key":"1967_CR33","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.neuint.2005.11.002","volume":"48","author":"S Engelborghs","year":"2006","unstructured":"Engelborghs S, Maertens K, Vloeberghs E, Aerts T, Somers N, Marien P et al (2006) Neuropsychological and behavioural correlates of CSF biomarkers in dementia. Neurochem Int 48:286\u2013295","journal-title":"Neurochem Int"},{"key":"1967_CR34","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/jcbfm.2013.135","volume":"33","author":"MA Erickson","year":"2013","unstructured":"Erickson MA, Banks WA (2013) Blood\u2013brain barrier dysfunction as a cause and consequence of Alzheimer\u2019s disease. J Cereb Blood Flow Metab 33:1500\u20131513","journal-title":"J Cereb Blood Flow Metab"},{"key":"1967_CR35","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0301-0082(00)00068-X","volume":"64","author":"E Farkas","year":"2001","unstructured":"Farkas E, Luiten PG (2001) Cerebral microvascular pathology in aging and Alzheimer\u2019s disease. Prog Neurobiol 64:575\u2013611","journal-title":"Prog Neurobiol"},{"key":"1967_CR36","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2353\/ajpath.2007.070105","volume":"171","author":"W Farris","year":"2007","unstructured":"Farris W, Schutz SG, Cirrito JR, Shankar GM, Sun X, George A et al (2007) Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy. Am J Pathol 171:241\u2013251","journal-title":"Am J Pathol"},{"key":"1967_CR37","doi-asserted-by":"publisher","first-page":"10347","DOI":"10.1073\/pnas.162366399","volume":"99","author":"A Garrigues","year":"2002","unstructured":"Garrigues A, Escargueil AE, Orlowski S (2002) The multidrug transporter, P-glycoprotein, actively mediates cholesterol redistribution in the cell membrane. Proc Natl Acad Sci USA 99:10347\u201310352","journal-title":"Proc Natl Acad Sci USA"},{"key":"1967_CR38","doi-asserted-by":"publisher","first-page":"7013","DOI":"10.1074\/jbc.270.13.7013","volume":"270","author":"SA Gravina","year":"1995","unstructured":"Gravina SA, Ho L, Eckman CB, Long KE, Otvos L Jr, Younkin LH et al (1995) Amyloid beta protein (A beta) in Alzheimer\u2019s disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43). J Biol Chem 270:7013\u20137016","journal-title":"J Biol Chem"},{"key":"1967_CR39","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/gps.1550","volume":"21","author":"M Haglund","year":"2006","unstructured":"Haglund M, Passant U, Sjobeck M, Ghebremedhin E, Englund E (2006) Cerebral amyloid angiopathy and cortical microinfarcts as putative substrates of vascular dementia. Int J Geriatr Psychiatry 21:681\u2013687","journal-title":"Int J Geriatr Psychiatry"},{"key":"1967_CR40","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3233\/JAD-170745","volume":"61","author":"R Harris","year":"2018","unstructured":"Harris R, Miners JS, Allen S, Love S (2018) VEGFR1 and VEGFR2 in Alzheimer\u2019s disease. J Alzheimers Dis 61:741\u2013752","journal-title":"J Alzheimers Dis"},{"key":"1967_CR41","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1523\/JNEUROSCI.0350-15.2016","volume":"36","author":"AM Hartz","year":"2016","unstructured":"Hartz AM, Zhong Y, Wolf A, LeVine H 3rd, Miller DS, Bauer B (2016) Abeta40 reduces P-glycoprotein at the blood\u2013brain barrier through the ubiquitin\u2013proteasome pathway. J Neurosci 36:1930\u20131941","journal-title":"J Neurosci"},{"key":"1967_CR42","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3389\/fnagi.2018.00186","volume":"10","author":"AMS Hartz","year":"2018","unstructured":"Hartz AMS, Zhong Y, Shen AN, Abner EL, Bauer B (2018) Preventing P-gp ubiquitination lowers Abeta brain levels in an Alzheimer\u2019s disease mouse model. Front Aging Neurosci 10:186","journal-title":"Front Aging Neurosci"},{"key":"1967_CR43","doi-asserted-by":"publisher","first-page":"e41636","DOI":"10.1371\/journal.pone.0041636","volume":"7","author":"CA Hawkes","year":"2012","unstructured":"Hawkes CA, Sullivan PM, Hands S, Weller RO, Nicoll JA, Carare RO (2012) Disruption of arterial perivascular drainage of amyloid-beta from the brains of mice expressing the human APOE epsilon4 allele. PLoS One 7:e41636","journal-title":"PLoS One"},{"issue":"427\u2013441","key":"1967_CR44","first-page":"e421","volume":"168","author":"YA Huang","year":"2017","unstructured":"Huang YA, Zhou B, Wernig M, Sudhof TC (2017) ApoE2, ApoE3, and ApoE4 differentially stimulate APP transcription and abeta secretion. Cell 168(427\u2013441):e421","journal-title":"Cell"},{"key":"1967_CR45","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nrn1387","volume":"5","author":"C Iadecola","year":"2004","unstructured":"Iadecola C (2004) Neurovascular regulation in the normal brain and in Alzheimer\u2019s disease. Nat Rev Neurosci 5:347\u2013360","journal-title":"Nat Rev Neurosci"},{"key":"1967_CR46","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1148\/radiol.2343040197","volume":"234","author":"NA Johnson","year":"2005","unstructured":"Johnson NA, Jahng GH, Weiner MW, Miller BL, Chui HC, Jagust WJ et al (2005) Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology 234:851\u2013859","journal-title":"Radiology"},{"key":"1967_CR47","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1002\/jnr.21667","volume":"86","author":"C Julien","year":"2008","unstructured":"Julien C, Tremblay C, Bendjelloul F, Phivilay A, Coulombe MA, Emond V et al (2008) Decreased drebrin mRNA expression in Alzheimer disease: correlation with tau pathology. J Neurosci Res 86:2292\u20132302","journal-title":"J Neurosci Res"},{"key":"1967_CR48","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/NEN.0b013e3181922348","volume":"68","author":"C Julien","year":"2009","unstructured":"Julien C, Tremblay C, Emond V, Lebbadi M, Salem N Jr, Bennett DA et al (2009) Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J Neuropathol Exp Neurol 68:48\u201358","journal-title":"J Neuropathol Exp Neurol"},{"key":"1967_CR49","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s40478-017-0477-x","volume":"5","author":"N Kakuda","year":"2017","unstructured":"Kakuda N, Miyasaka T, Iwasaki N, Nirasawa T, Wada-Kakuda S, Takahashi-Fujigasaki J et al (2017) Distinct deposition of amyloid-beta species in brains with Alzheimer\u2019s disease pathology visualized with MALDI imaging mass spectrometry. Acta Neuropathol Commun 5:73","journal-title":"Acta Neuropathol Commun"},{"key":"1967_CR50","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/j.1471-4159.1989.tb07399.x","volume":"53","author":"RN Kalaria","year":"1989","unstructured":"Kalaria RN, Harik SI (1989) Reduced glucose transporter at the blood\u2013brain barrier and in cerebral cortex in Alzheimer disease. J Neurochem 53:1083\u20131088","journal-title":"J Neurochem"},{"key":"1967_CR51","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/0006-8993(95)01250-8","volume":"705","author":"RN Kalaria","year":"1995","unstructured":"Kalaria RN, Pax AB (1995) Increased collagen content of cerebral microvessels in Alzheimer\u2019s disease. Brain Res 705:349\u2013352","journal-title":"Brain Res"},{"key":"1967_CR52","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/0169-328X(95)00180-Z","volume":"35","author":"RN Kalaria","year":"1996","unstructured":"Kalaria RN, Premkumar DR, Pax AB, Cohen DL, Lieberburg I (1996) Production and increased detection of amyloid beta protein and amyloidogenic fragments in brain microvessels, meningeal vessels and choroid plexus in Alzheimer\u2019s disease. Brain Res Mol Brain Res 35:58\u201368","journal-title":"Brain Res Mol Brain Res"},{"key":"1967_CR53","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.bbadis.2015.12.023","volume":"1862","author":"A Kapasi","year":"2016","unstructured":"Kapasi A, Schneider JA (2016) Vascular contributions to cognitive impairment, clinical Alzheimer\u2019s disease, and dementia in older persons. Biochim Biophys Acta 1862:878\u2013886","journal-title":"Biochim Biophys Acta"},{"key":"1967_CR54","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-2377-9-3","volume":"9","author":"HA Keage","year":"2009","unstructured":"Keage HA, Carare RO, Friedland RP, Ince PG, Love S, Nicoll JA et al (2009) Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review. BMC Neurol 9:3","journal-title":"BMC Neurol"},{"key":"1967_CR55","doi-asserted-by":"publisher","first-page":"11982","DOI":"10.1074\/jbc.M700356200","volume":"282","author":"PH Kuhn","year":"2007","unstructured":"Kuhn PH, Marjaux E, Imhof A, De Strooper B, Haass C, Lichtenthaler SF (2007) Regulated intramembrane proteolysis of the interleukin-1 receptor II by alpha-, beta-, and gamma-secretase. J Biol Chem 282:11982\u201311995","journal-title":"J Biol Chem"},{"key":"1967_CR56","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1750-3639.2007.00075.x","volume":"17","author":"D Kuhnke","year":"2007","unstructured":"Kuhnke D, Jedlitschky G, Grube M, Krohn M, Jucker M, Mosyagin I et al (2007) MDR1-P-Glycoprotein (ABCB1) mediates transport of Alzheimer\u2019s amyloid-beta peptides: implications for the mechanisms of Abeta clearance at the blood\u2013brain barrier. Brain Pathol 17:347\u2013353","journal-title":"Brain Pathol"},{"key":"1967_CR57","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3233\/JAD-122317","volume":"34","author":"DR Lachno","year":"2013","unstructured":"Lachno DR, Evert BA, Vanderstichele H, Robertson M, Demattos RB, Konrad RJ et al (2013) Validation of assays for measurement of amyloid-beta peptides in cerebrospinal fluid and plasma specimens from patients with Alzheimer\u2019s disease treated with solanezumab. J Alzheimers Dis 34:897\u2013910","journal-title":"J Alzheimers Dis"},{"key":"1967_CR58","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1046\/j.1471-4159.2001.00113.x","volume":"76","author":"FC Lam","year":"2001","unstructured":"Lam FC, Liu R, Lu P, Shapiro AB, Renoir JM, Sharom FJ, Reiner PB (2001) beta-Amyloid efflux mediated by p-glycoprotein. J Neurochem 76:1121\u20131128","journal-title":"J Neurochem"},{"key":"1967_CR59","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/nan.12295","volume":"43","author":"FX Lepelletier","year":"2017","unstructured":"Lepelletier FX, Mann DM, Robinson AC, Pinteaux E, Boutin H (2017) Early changes in extracellular matrix in Alzheimer\u2019s disease. Neuropathol Appl Neurobiol 43:167\u2013182","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1967_CR60","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s00401-015-1522-0","volume":"131","author":"S Love","year":"2016","unstructured":"Love S, Miners JS (2016) Cerebrovascular disease in ageing and Alzheimer\u2019s disease. Acta Neuropathol 131:645\u2013658","journal-title":"Acta Neuropathol"},{"key":"1967_CR61","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1160\/TH05-06-0413","volume":"95","author":"M Maccarrone","year":"2006","unstructured":"Maccarrone M, Fiori A, Bari M, Granata F, Gasperi V, De Stefano ME et al (2006) Regulation by cannabinoid receptors of anandamide transport across the blood\u2013brain barrier and through other endothelial cells. Thromb Haemost 95:117\u2013127","journal-title":"Thromb Haemost"},{"key":"1967_CR62","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0304-3940(96)13294-8","volume":"221","author":"DM Mann","year":"1997","unstructured":"Mann DM, Iwatsubo T, Pickering-Brown SM, Owen F, Saido TC, Perry RH (1997) Preferential deposition of amyloid beta protein (Abeta) in the form Abeta40 in Alzheimer\u2019s disease is associated with a gene dosage effect of the apolipoprotein E E4 allele. Neurosci Lett 221:81\u201384","journal-title":"Neurosci Lett"},{"key":"1967_CR63","doi-asserted-by":"publisher","first-page":"22212","DOI":"10.1074\/jbc.M115.644823","volume":"290","author":"AC Mar","year":"2015","unstructured":"Mar AC, Chu CH, Lee HJ, Chien CW, Cheng JJ, Yang SH et al (2015) Interleukin-1 receptor type 2 acts with c-Fos to enhance the expression of interleukin-6 and vascular endothelial growth factor A in colon cancer cells and induce angiogenesis. J Biol Chem 290:22212\u201322224","journal-title":"J Biol Chem"},{"key":"1967_CR64","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1093\/brain\/awu043","volume":"137","author":"N Mattsson","year":"2014","unstructured":"Mattsson N, Tosun D, Insel PS, Simonson A, Jack CR Jr, Beckett LA et al (2014) Association of brain amyloid-beta with cerebral perfusion and structure in Alzheimer\u2019s disease and mild cognitive impairment. Brain 137:1550\u20131561","journal-title":"Brain"},{"key":"1967_CR65","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1126\/science.1197623","volume":"330","author":"KG Mawuenyega","year":"2010","unstructured":"Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC et al (2010) Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease. Science 330:1774","journal-title":"Science"},{"key":"1967_CR66","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.brainres.2008.06.124","volume":"1230","author":"MC Miller","year":"2008","unstructured":"Miller MC, Tavares R, Johanson CE, Hovanesian V, Donahue JE, Gonzalez L et al (2008) Hippocampal RAGE immunoreactivity in early and advanced Alzheimer\u2019s disease. Brain Res 1230:273\u2013280","journal-title":"Brain Res"},{"key":"1967_CR67","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1750-3639.2011.00486.x","volume":"21","author":"JS Miners","year":"2011","unstructured":"Miners JS, Kehoe P, Love S (2011) Neprilysin protects against cerebral amyloid angiopathy and Abeta-induced degeneration of cerebrovascular smooth muscle cells. Brain Pathol 21:594\u2013605","journal-title":"Brain Pathol"},{"key":"1967_CR68","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1097\/01.jnen.0000240463.87886.9a","volume":"65","author":"JS Miners","year":"2006","unstructured":"Miners JS, Van Helmond Z, Chalmers K, Wilcock G, Love S, Kehoe PG (2006) Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy. J Neuropathol Exp Neurol 65:1012\u20131021","journal-title":"J Neuropathol Exp Neurol"},{"key":"1967_CR69","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM et al (1991) The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41:479\u2013486","journal-title":"Neurology"},{"key":"1967_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW et al (2012) National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol 123:1\u201311","journal-title":"Acta Neuropathol"},{"key":"1967_CR71","first-page":"383796","volume":"2012","author":"NN Nalivaeva","year":"2012","unstructured":"Nalivaeva NN, Belyaev ND, Zhuravin IA, Turner AJ (2012) The Alzheimer\u2019s amyloid-degrading peptidase, neprilysin: can we control it? Int J Alzheimers Dis 2012:383796","journal-title":"Int J Alzheimers Dis"},{"key":"1967_CR72","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0006-8993(99)01361-X","volume":"828","author":"R Natte","year":"1999","unstructured":"Natte R, de Boer WI, Maat-Schieman ML, Baelde HJ, Vinters HV, Roos RA et al (1999) Amyloid beta precursor protein-mRNA is expressed throughout cerebral vessel walls. Brain Res 828:179\u2013183","journal-title":"Brain Res"},{"key":"1967_CR73","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.mad.2005.09.022","volume":"127","author":"L Parnetti","year":"2006","unstructured":"Parnetti L, Lanari A, Silvestrelli G, Saggese E, Reboldi P (2006) Diagnosing prodromal Alzheimer\u2019s disease: role of CSF biochemical markers. Mech Ageing Dev 127:129\u2013132","journal-title":"Mech Ageing Dev"},{"key":"1967_CR74","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1212\/WNL.58.11.1629","volume":"58","author":"LA Pfeifer","year":"2002","unstructured":"Pfeifer LA, White LR, Ross GW, Petrovitch H, Launer LJ (2002) Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurology 58:1629\u20131634","journal-title":"Neurology"},{"key":"1967_CR75","first-page":"201","volume":"37","author":"M Piert","year":"1996","unstructured":"Piert M, Koeppe RA, Giordani B, Berent S, Kuhl DE (1996) Diminished glucose transport and phosphorylation in Alzheimer\u2019s disease determined by dynamic FDG-PET. J Nucl Med 37:201\u2013208","journal-title":"J Nucl Med"},{"key":"1967_CR76","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1007\/s00415-012-6520-8","volume":"259","author":"D Renard","year":"2012","unstructured":"Renard D, Castelnovo G, Wacongne A, Le Floch A, Thouvenot E, Mas J et al (2012) Interest of CSF biomarker analysis in possible cerebral amyloid angiopathy cases defined by the modified Boston criteria. J Neurol 259:2429\u20132433","journal-title":"J Neurol"},{"key":"1967_CR77","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/jnen\/62.9.885","volume":"62","author":"T Revesz","year":"2003","unstructured":"Revesz T, Ghiso J, Lashley T, Plant G, Rostagno A, Frangione B et al (2003) Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view. J Neuropathol Exp Neurol 62:885\u2013898","journal-title":"J Neuropathol Exp Neurol"},{"key":"1967_CR78","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1111\/j.1532-5415.2009.02521.x","volume":"57","author":"JA Schneider","year":"2009","unstructured":"Schneider JA (2009) High blood pressure and microinfarcts: a link between vascular risk factors, dementia, and clinical Alzheimer\u2019s disease. J Am Geriatr Soc 57:2146\u20132147","journal-title":"J Am Geriatr Soc"},{"key":"1967_CR79","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1172\/JCI10498","volume":"106","author":"M Shibata","year":"2000","unstructured":"Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B et al (2000) Clearance of Alzheimer\u2019s amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood\u2013brain barrier. J Clin Invest 106:1489\u20131499","journal-title":"J Clin Invest"},{"key":"1967_CR80","doi-asserted-by":"publisher","first-page":"21895","DOI":"10.1074\/jbc.M008511200","volume":"276","author":"K Shirotani","year":"2001","unstructured":"Shirotani K, Tsubuki S, Iwata N, Takaki Y, Harigaya W, Maruyama K et al (2001) Neprilysin degrades both amyloid beta peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases. J Biol Chem 276:21895\u201321901","journal-title":"J Biol Chem"},{"key":"1967_CR81","doi-asserted-by":"publisher","first-page":"4044","DOI":"10.1172\/JCI96817","volume":"128","author":"RL Szabady","year":"2018","unstructured":"Szabady RL, Louissaint C, Lubben A, Xie B, Reeksting S, Tuohy C et al (2018) Intestinal P-glycoprotein exports endocannabinoids to prevent inflammation and maintain homeostasis. J Clin Invest 128:4044\u20134056","journal-title":"J Clin Invest"},{"key":"1967_CR82","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/j.1365-2990.2005.00652.x","volume":"31","author":"M Tanskanen","year":"2005","unstructured":"Tanskanen M, Lindsberg PJ, Tienari PJ, Polvikoski T, Sulkava R, Verkkoniemi A et al (2005) Cerebral amyloid angiopathy in a 95+\u2009cohort: complement activation and apolipoprotein E (ApoE) genotype. Neuropathol Appl Neurobiol 31:589\u2013599","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1967_CR83","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/jnen\/61.3.282","volume":"61","author":"DR Thal","year":"2002","unstructured":"Thal DR, Ghebremedhin E, Rub U, Yamaguchi H, Del Tredici K, Braak H (2002) Two types of sporadic cerebral amyloid angiopathy. J Neuropathol Exp Neurol 61:282\u2013293","journal-title":"J Neuropathol Exp Neurol"},{"key":"1967_CR84","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00401-008-0366-2","volume":"115","author":"DR Thal","year":"2008","unstructured":"Thal DR, Griffin WS, de Vos RA, Ghebremedhin E (2008) Cerebral amyloid angiopathy and its relationship to Alzheimer\u2019s disease. Acta Neuropathol 115:599\u2013609","journal-title":"Acta Neuropathol"},{"key":"1967_CR85","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791\u20131800","journal-title":"Neurology"},{"key":"1967_CR86","doi-asserted-by":"crossref","unstructured":"Thomsen MS, Routhe LJ, Moos T (2017) The vascular basement membrane in the healthy and pathological brain. J Cereb Blood Flow Metab 271678X17722436","DOI":"10.1177\/0271678X17722436"},{"key":"1967_CR87","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.psyneuen.2016.11.028","volume":"77","author":"MT Traversy","year":"2017","unstructured":"Traversy MT, Vandal M, Tremblay C, Tournissac M, Giguere-Rancourt A, Bennett AD et al (2017) Altered cerebral insulin response in transgenic mice expressing the epsilon-4 allele of the human apolipoprotein E gene. Psychoneuroendocrinology 77:203\u2013210","journal-title":"Psychoneuroendocrinology"},{"key":"1967_CR88","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/jnen\/nlw109","volume":"76","author":"C Tremblay","year":"2017","unstructured":"Tremblay C, Francois A, Delay C, Freland L, Vandal M, Bennett DA et al (2017) Association of neuropathological markers in the parietal cortex with antemortem cognitive function in persons with mild cognitive impairment and Alzheimer disease. J Neuropathol Exp Neurol 76:70\u201388","journal-title":"J Neuropathol Exp Neurol"},{"key":"1967_CR89","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3233\/JAD-2007-12411","volume":"12","author":"C Tremblay","year":"2007","unstructured":"Tremblay C, Pilote M, Phivilay A, Emond V, Bennett DA, Calon F (2007) Biochemical characterization of Abeta and tau pathologies in mild cognitive impairment and Alzheimer\u2019s disease. J Alzheimers Dis 12:377\u2013390","journal-title":"J Alzheimers Dis"},{"key":"1967_CR90","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1097\/NEN.0b013e31822c62cf","volume":"70","author":"C Tremblay","year":"2011","unstructured":"Tremblay C, St-Amour I, Schneider J, Bennett DA, Calon F (2011) Accumulation of transactive response DNA binding protein 43 in mild cognitive impairment and Alzheimer disease. J Neuropathol Exp Neurol 70:788\u2013798","journal-title":"J Neuropathol Exp Neurol"},{"key":"1967_CR91","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/brain\/awr298","volume":"135","author":"DM Assema van","year":"2012","unstructured":"van Assema DM, Lubberink M, Bauer M, van der Flier WM, Schuit RC, Windhorst AD et al (2012) Blood\u2013brain barrier P-glycoprotein function in Alzheimer\u2019s disease. Brain 135:181\u2013189","journal-title":"Brain"},{"key":"1967_CR92","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0092-8674(00)81370-7","volume":"87","author":"A Helvoort van","year":"1996","unstructured":"van Helvoort A, Smith AJ, Sprong H, Fritzsche I, Schinkel AH, Borst P et al (1996) MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell 87:507\u2013517","journal-title":"Cell"},{"key":"1967_CR93","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nature25739","volume":"554","author":"M Vanlandewijck","year":"2018","unstructured":"Vanlandewijck M, He L, Mae MA, Andrae J, Ando K, Del Gaudio F et al (2018) A molecular atlas of cell types and zonation in the brain vasculature. Nature 554:475\u2013480","journal-title":"Nature"},{"key":"1967_CR94","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/ana.21694","volume":"66","author":"MM Verbeek","year":"2009","unstructured":"Verbeek MM, Kremer BP, Rikkert MO, Van Domburg PH, Skehan ME, Greenberg SM (2009) Cerebrospinal fluid amyloid beta(40) is decreased in cerebral amyloid angiopathy. Ann Neurol 66:245\u2013249","journal-title":"Ann Neurol"},{"key":"1967_CR95","first-page":"311","volume":"18","author":"HV Vinters","year":"1987","unstructured":"Vinters HV (1987) Cerebral amyloid angiopathy. A critical review. Stroke 18:311\u2013324","journal-title":"A critical review. Stroke"},{"key":"1967_CR96","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/00008571-200210000-00005","volume":"12","author":"S Vogelgesang","year":"2002","unstructured":"Vogelgesang S, Cascorbi I, Schroeder E, Pahnke J, Kroemer HK, Siegmund W et al (2002) Deposition of Alzheimer\u2019s beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans. Pharmacogenetics 12:535\u2013541","journal-title":"Pharmacogenetics"},{"key":"1967_CR97","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.nbd.2008.12.007","volume":"34","author":"V Vukic","year":"2009","unstructured":"Vukic V, Callaghan D, Walker D, Lue LF, Liu QY, Couraud PO, Romero IA, Weksler B, Stanimirovic DB, Zhang W (2009) Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer\u2019s brain is mediated by the JNK\u2013AP1 signaling pathway. Neurobiol Dis 34:95\u2013106","journal-title":"Neurobiol Dis"},{"key":"1967_CR98","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1006\/bbrc.2000.3554","volume":"276","author":"E Wang","year":"2000","unstructured":"Wang E, Casciano CN, Clement RP, Johnson WW (2000) Cholesterol interaction with the daunorubicin binding site of P-glycoprotein. Biochem Biophys Res Commun 276:909\u2013916","journal-title":"Biochem Biophys Res Commun"},{"key":"1967_CR99","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3233\/JAD-2012-120454","volume":"31","author":"S Wang","year":"2012","unstructured":"Wang S, Qaisar U, Yin X, Grammas P (2012) Gene expression profiling in Alzheimer\u2019s disease brain microvessels. J Alzheimers Dis 31:193\u2013205","journal-title":"J Alzheimers Dis"},{"key":"1967_CR100","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1471-4159.2010.06899.x","volume":"115","author":"S Wang","year":"2010","unstructured":"Wang S, Wang R, Chen L, Bennett DA, Dickson DW, Wang DS (2010) Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer\u2019s brain. J Neurochem 115:47\u201357","journal-title":"J Neurochem"},{"key":"1967_CR101","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/alzrt6","volume":"1","author":"RO Weller","year":"2009","unstructured":"Weller RO, Preston SD, Subash M, Carare RO (2009) Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease. Alzheimers Res Ther 1:6","journal-title":"Alzheimers Res Ther"},{"key":"1967_CR102","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.brainres.2010.08.034","volume":"1358","author":"HC Wijesuriya","year":"2010","unstructured":"Wijesuriya HC, Bullock JY, Faull RL, Hladky SB, Barrand MA (2010) ABC efflux transporters in brain vasculature of Alzheimer\u2019s subjects. Brain Res 1358:228\u2013238","journal-title":"Brain Res"},{"key":"1967_CR103","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.2353\/ajpath.2007.070050","volume":"171","author":"MM Wilhelmus","year":"2007","unstructured":"Wilhelmus MM, Otte-Holler I, van Triel JJ, Veerhuis R, Maat-Schieman ML, Bu G et al (2007) Lipoprotein receptor-related protein-1 mediates amyloid-beta-mediated cell death of cerebrovascular cells. Am J Pathol 171:1989\u20131999","journal-title":"Am J Pathol"},{"key":"1967_CR104","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1037\/0882-7974.17.2.179","volume":"17","author":"RS Wilson","year":"2002","unstructured":"Wilson RS, Beckett LA, Barnes LL, Schneider JA, Bach J, Evans DA et al (2002) Individual differences in rates of change in cognitive abilities of older persons. Psychol Aging 17:179\u2013193","journal-title":"Psychol Aging"},{"key":"1967_CR105","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12883-015-0327-z","volume":"15","author":"ZQ Xue","year":"2015","unstructured":"Xue ZQ, He ZW, Yu JJ, Cai Y, Qiu WY, Pan A et al (2015) Non-neuronal and neuronal BACE1 elevation in association with angiopathic and leptomeningeal beta-amyloid deposition in the human brain. BMC Neurol 15:71","journal-title":"BMC Neurol"},{"key":"1967_CR106","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/j.1749-6632.2000.tb06404.x","volume":"903","author":"JH Xuereb","year":"2000","unstructured":"Xuereb JH, Brayne C, Dufouil C, Gertz H, Wischik C, Harrington C et al (2000) Neuropathological findings in the very old. Results from the first 101 brains of a population-based longitudinal study of dementing disorders. Ann N Y Acad Sci 903:490\u2013496","journal-title":"Ann N Y Acad Sci"},{"key":"1967_CR107","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1749-6632.2002.tb04797.x","volume":"977","author":"M Yamada","year":"2002","unstructured":"Yamada M (2002) Risk factors for cerebral amyloid angiopathy in the elderly. Ann N Y Acad Sci 977:37\u201344","journal-title":"Ann N Y Acad Sci"},{"key":"1967_CR108","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.3390\/ijms18091965","volume":"18","author":"Y Yamazaki","year":"2017","unstructured":"Yamazaki Y, Kanekiyo T (2017) Blood\u2013brain barrier dysfunction and the pathogenesis of Alzheimer\u2019s disease. Int J Mol Sci 18:1965","journal-title":"Int J Mol Sci"},{"key":"1967_CR109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2006.11.089","volume":"1134","author":"S Yousif","year":"2007","unstructured":"Yousif S, Marie-Claire C, Roux F, Scherrmann JM, Decleves X (2007) Expression of drug transporters at the blood\u2013brain barrier using an optimized isolated rat brain microvessel strategy. Brain Res 1134:1\u201311","journal-title":"Brain Res"},{"key":"1967_CR110","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1749-6632.1997.tb48467.x","volume":"826","author":"C Zarow","year":"1997","unstructured":"Zarow C, Barron E, Chui HC, Perlmutter LS (1997) Vascular basement membrane pathology and Alzheimer\u2019s disease. Ann N Y Acad Sci 826:147\u2013160","journal-title":"Ann N Y Acad Sci"},{"key":"1967_CR111","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.nbd.2016.07.007","volume":"107","author":"E Zenaro","year":"2017","unstructured":"Zenaro E, Piacentino G, Constantin G (2017) The blood\u2013brain barrier in Alzheimer\u2019s disease. Neurobiol Dis 107:41\u201356","journal-title":"Neurobiol Dis"},{"key":"1967_CR112","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.tins.2005.02.001","volume":"28","author":"BV Zlokovic","year":"2005","unstructured":"Zlokovic BV (2005) Neurovascular mechanisms of Alzheimer\u2019s neurodegeneration. Trends Neurosci 28:202\u2013208","journal-title":"Trends Neurosci"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-019-01967-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-019-01967-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-019-01967-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T16:10:16Z","timestamp":1720973416000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-019-01967-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,7]]},"references-count":112,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["1967"],"URL":"https:\/\/doi.org\/10.1007\/s00401-019-01967-4","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,7]]},"assertion":[{"value":"14 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}